Fig. 2

The number and timeline of reviewed articles reporting outbreaks related to bacterial and fungal contamination of intravenous fluids and medicines in healthcare facilities in upper middle-income countries (n = 21), lower middle-income countries (n = 25) and low-income countries (n = 4)